← Leaderboards
Michael R Betts
University Of Pennsylvania
$25,350,826
Attributed
$42,789,670
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,604,749 · 20
By mechanism
UC4$17,818,862 · 1
R01$14,304,319 · 5
P01$12,570,442 · 7
U19$2,806,899 · 2
P30$1,186,971 · 1
R21$886,875 · 2
Top collaborators
- Katharine June Bar5 shared
- David H Canaday5 shared
- Brad R Jones3 shared
- Ole Schmeltz SãGaard3 shared
- Michael D Feldman2 shared
- Klaus H. Kaestner2 shared
- Jason H. Moore2 shared
- Ali Naji2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Rob R McGregor$273,406
- Rob R Macgregor$4,980,820
- Ronald G Collman$30,299,814
- Drew Weissman$21,263,557
- Phillip A. Scott$24,920,033
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteInfectionImmune ResponseResponseBaseCd8b1 GenePropertyProgramsViralHiv InfectionsImmuneCell PhysiologyCd4 Positive T LymphocytesPhenotypeViremiaHiv VaccineT Cell ResponseMacaca MulattaVaccinationMediatingAntiretroviral TherapyImmunityImmunologics
Grant awards (68)
Multiomic strategies to assess HIV reservoir persistence$844,008
R01 · FY2025 · AI · contact PI
In vivo targeting of T cells to Enable an HIV Cure$556,722
P01 · FY2025 · AI · contact PI
Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses$545,151
R01 · FY2025 · AI · contact PI
Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses$149,150
R01 · FY2025 · AI · contact PI
Multiomic strategies to assess HIV reservoir persistence$844,008
R01 · FY2024 · AI · contact PI
Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses$694,301
R01 · FY2024 · AI · contact PI
Multiomic strategies to assess HIV reservoir persistence$810,146
R01 · FY2023 · AI · contact PI
Viral ASAPseq definition of CD4+ T cell viral reservoirs$203,125
R21 · FY2023 · AI · contact PI
Viral ASAPseq definition of CD4+ T cell viral reservoirs$243,750
R21 · FY2022 · AI · contact PI
Immunological Strategies to Modulate SIV Rebound Following ART Interruption$1,497,359
P01 · FY2021 · AI · contact PI
Project 2 - Michael Betts$538,363
P01 · FY2021 · AI · contact PI
Admin Core$97,387
P01 · FY2021 · AI · contact PI
Penn integrated Human Pancreas procurement and Analysis Program$5,569,273
UC4 · FY2020 · DK
Immunological Strategies to Modulate SIV Rebound Following ART Interruption$1,510,883
P01 · FY2020 · AI · contact PI
Project 2 - Michael Betts$285,233
P01 · FY2020 · AI · contact PI
Admin Core$67,470
P01 · FY2020 · AI · contact PI
Immunological Strategies to Modulate SIV Rebound Following ART Interruption$1,541,832
P01 · FY2019 · AI · contact PI
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node$645,687
R01 · FY2019 · AI · contact PI
Project 2 - Michael Betts$284,161
P01 · FY2019 · AI · contact PI
Admin Core$69,291
P01 · FY2019 · AI · contact PI
Immunological Strategies to Modulate SIV Rebound Following ART Interruption$1,614,482
P01 · FY2018 · AI · contact PI
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node$649,109
R01 · FY2018 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$444,759
R01 · FY2018 · AI
Project 2 - Michael Betts$384,916
P01 · FY2018 · AI · contact PI
Admin Core$73,673
P01 · FY2018 · AI · contact PI
Immunological Strategies to Modulate SIV Rebound Following ART Interruption$1,650,523
P01 · FY2017 · AI · contact PI
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node$652,463
R01 · FY2017 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$646,869
R01 · FY2017 · AI
T cell functionality and control of HIV infection$463,259
R01 · FY2017 · AI · contact PI
Project 2 - Michael Betts$376,621
P01 · FY2017 · AI · contact PI
Admin Core$74,261
P01 · FY2017 · AI · contact PI
Penn integrated Human Pancreas procurement and Analysis Program$12,249,589
UC4 · FY2016 · DK
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node$656,544
R01 · FY2016 · AI · contact PI
T cell functionality and control of HIV infection$463,259
R01 · FY2016 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$454,879
R01 · FY2016 · AI
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node$704,645
R01 · FY2015 · AI · contact PI
T cell functionality and control of HIV infection$463,259
R01 · FY2015 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$463,001
R01 · FY2015 · AI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$470,090
R01 · FY2014 · AI
T cell functionality and control of HIV infection$463,259
R01 · FY2014 · AI · contact PI
CD8+ T cell effector transcriptional programming in SIV infection$760,381
R56 · FY2013 · AI · contact PI
T cell functionality and control of HIV infection$435,148
R01 · FY2013 · AI · contact PI
Immunology Core$219,697
P30 · FY2013 · DK · contact PI
CD200-CD200R expression and chronic immune activation in HIV infection$200,000
R21 · FY2013 · AI · contact PI
T Cell Functionality and Control of Acute HIV Infection$498,746
R01 · FY2012 · AI · contact PI
CD200-CD200R expression and chronic immune activation in HIV infection$240,000
R21 · FY2012 · AI · contact PI
Immunology Core$234,659
P30 · FY2012 · DK · contact PI
T Cell Functionality After DNA and Adjuvant Vaccination$647,117
P01 · FY2011 · AI · contact PI
T Cell Functionality and Control of Acute HIV Infection$487,023
R01 · FY2011 · AI · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$413,402
U19 · FY2011 · AI · contact PI
Immunology Core$236,250
P30 · FY2011 · DK · contact PI
T Cell Functionality and Control of Acute HIV Infection$484,854
R01 · FY2010 · AI · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$449,811
U19 · FY2010 · AI · contact PI
T Cell Functionality After DNA and Adjuvant Vaccination$356,702
P01 · FY2010 · AI · contact PI
Immunology Core$236,250
P30 · FY2010 · DK · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$776,411
U19 · FY2009 · AI · contact PI
T Cell Functionality and Control of Acute HIV Infection$409,053
R01 · FY2009 · AI · contact PI
T Cell Functionality After DNA and Adjuvant Vaccination$349,749
P01 · FY2009 · AI · contact PI
Immunology Core$260,115
P30 · FY2009 · DK · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$199,998
U19 · FY2009 · AI · contact PI
T Cell Functionality and Control of Acute HIV Infection$48,656
R01 · FY2009 · AI · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$468,772
U19 · FY2008 · AI · contact PI
T Cell Functionality and Control of Acute HIV Infection$412,993
R01 · FY2008 · AI · contact PI
T Cell Functionality After DNA and Adjuvant Vaccination$298,082
P01 · FY2008 · AI · contact PI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus$498,505
U19 · FY2007 · AI · contact PI
T Cell Functionality After DNA and Adjuvant Vaccination$295,615
P01 · FY2007 · AI · contact PI
Impact of CD8+ T cell functionality on HIV viral escape$108,000
K22 · FY2006 · AI · contact PI
Impact of CD8+ T cell functionality on HIV viral escape$162,000
K22 · FY2005 · AI